Precision Biosciences Inc (NASDAQ:DTIL) shares, rose in value on Thursday, April 16, with the stock price up by 0.20% to the previous day’s close as strong demand from buyers drove the stock to $5.02.
Actively observing the price movement in the last trading, the stock closed the session at $5.01, falling within a range of $4.9 and $5.15. The value of beta (5-year monthly) was 1.584 whereas the PE ratio was 2.65 over 12-month period. Referring to stock’s 52-week performance, its high was $13.44, and the low was $3.61. On the whole, DTIL has fluctuated by 0.20% over the past month.
With the market capitalization of Precision Biosciences Inc currently standing at about $52.61 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-25.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that DTIL’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of DTIL currently trading nearly 5.21% and -0.21% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.86, while the 7-day volatility ratio is showing 9.26% which for the 30-day chart, stands at 8.66%. Furthermore, Precision Biosciences Inc (DTIL)’s beta value is 1.48, and its average true range (ATR) is 0.42.
A comparison of Precision Biosciences Inc (DTIL) with its peers suggests the former has fared considerably weaker in the market. DTIL showed an intraday change of 0.20% in last session, and over the past year, it shrunk by -60.99%%.
Data on historical trading for Precision Biosciences Inc (NASDAQ:DTIL) indicates that the trading volumes over the past 10 days have averaged 0.3 and over the past 3 months, they’ve averaged 160.12K. According to company’s latest data on outstanding shares, there are 8.20 million shares outstanding.
Nearly 15.00% of Precision Biosciences Inc’s shares belong to company insiders and institutional investors own 95.38% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.75 million shares as on 2025-03-31, resulting in a short ratio of 5.59. According to the data, the short interest in Precision Biosciences Inc (DTIL) stood at 726.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.74 million. The stock has risen by 31.76% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the DTIL stock heading into the next quarter.
